{"id":1240,"date":"2026-05-07T09:52:43","date_gmt":"2026-05-07T09:52:43","guid":{"rendered":"http:\/\/c-ciarn.ca\/?p=1240"},"modified":"2026-05-07T09:52:43","modified_gmt":"2026-05-07T09:52:43","slug":"nitric-oxide-zero-and-tnf-release-in-culture-media-were-measured-as-markers-from-the-inflammatory-response","status":"publish","type":"post","link":"https:\/\/c-ciarn.ca\/?p=1240","title":{"rendered":"\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response"},"content":{"rendered":"<p>\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response. in lots of demyelinating illnesses, including multiple sclerosis (MS). Although cytotoxic actions of myelin-specific T cells continues to be incriminated for the MS immunopathology generally, accumulating evidence signifies that microglia-mediated innate immune responses enjoy a significant role in progressive demyelination1 also. In demyelinating circumstances, microglia could be turned on by myelin particles or with the inflammatory cytokines released from turned on T cells, such as for example IFN-. Nodules of turned on microglia have already been noticed encircling the white matter plaques in sufferers with MS, a sensation that is even more prominent in intensifying MS than in early MS1. The L-778123 HCl functions of microglia in MS are very different and controversial still. Preliminary microglial activation in a energetic lesion site provides been shown to become pro-inflammatory and result in demyelination and axonal damage. For example, a recently available study showed an in depth association between microglial activation and scientific impairment in MS sufferers2. In more complex <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=gene&#038;cmd=Retrieve&#038;dopt=full_report&#038;list_uids=998\">CDC42<\/a> lesions, however, the function of microglia and infiltrated macrophages may be more beneficial and involve phagocytosis of myelin debris and enhancement of remyelination and regeneration3,4. Because of these dualistic roles in demyelination\/remyelination, microglia represent rational but complex targets for the clinical management of MS. Depending on the environmental milieu, microglia vary in their phenotype. Whereas the classically activated M1 phenotype is usually associated with increased antigen presentation and the production of toxic cytokines and reactive oxygen species, the alternatively activated M2 phenotype is usually devoted to the clearance of cellular debris, resolution of local inflammation, and the release of trophic factors that foster recovery after neurological injury5,6. Phenotype polarization is known to be affected by the progression of many neurological diseases including MS7, stroke8, traumatic brain injury9, and spinal cord injury10,11, and may therefore represent a potential therapeutic target for neurological disorders. Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been studied for their beneficial effects in many animal models of neurodegenerative diseases, such as Alzheimer&#8217;s disease12,13,14and Parkinson&#8217;s disease15. Several mechanisms are known to underlie n-3 PUFA-mediated neuroprotection, such as suppression of cell death, inhibition of inflammation, and promotion of neurogenesis. Recent studies have also examined the effect of n-3 PUFAs on white matter pathology. For example, n-3 PUFA supplementation is usually linked with fewer white matter lesions and improved executive function in older adults16,17. Furthermore, several epidemiological studies suggest that n-3 PUFA supplementation is usually associated <a href=\"https:\/\/www.adooq.com\/l-778123-hcl.html\">L-778123 HCl<\/a> with improved clinical outcomes in MS patients18,19. Beneficial effects of n-3 PUFA supplementation have also been reported in the experimental autoimmune encephalomyelitis (EAE) animal model of MS and attributed to the modulatory effect of docosahexaenoic acid (DHA) on dendritic cell-dependent T cell activation20. The effect of n-3 PUFAs on microglia responses in L-778123 HCl MS or other white matter pathology, however, has not been investigated. In the current study, we used primary microglial cultures and an animal model of cuprizone-induced demyelination to elucidate the action of n-3 PUFAs on microglial responses to myelin pathology. We found that DHA and eicosapentaenoic acid (EPA), the main n-3 PUFAs in the central nervous system, concentration-dependently inhibited the microglial release of inflammatory mediators in response to myelin and IFN- stimulation and boosted myelin phagocytosisin vitro. Further mechanistic studies exhibited that DHA and EPA can shift microglial polarization toward the M2 phenotype under physiologicalin vitrocondition and inhibit M1 polarization under inflammatory conditions.In vivostudies further confirm that n-3 PUFA supplementation reduced cuprizone-induced demyelination and improved motor and cognitive abilities. These beneficial effects of n-3 PUFAs in the animal model were also accompanied by a shift to the M2 microglial phenotypein vivo. == Results == == DHA and EPA inhibit inflammatory responses in microglia == In order to determine whether DHA and EPA can modulate microglial activation, primary microglia were treated with DHA or EPA for 24 hrs followed by LPS stimulation (2.5 ng\/mL) for another 24 hrs. Nitric oxide (NO) and TNF release in culture media were measured as markers of the inflammatory response. As shown inFigure 1, pretreatment with DHA significantly attenuated LPS-induced NO and TNF release.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response. in lots of demyelinating illnesses, including multiple sclerosis (MS). Although cytotoxic actions of myelin-specific T cells continues to be incriminated for the MS&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22],"tags":[],"class_list":["post-1240","post","type-post","status-publish","format-standard","hentry","category-hats"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response - SGLT inhibitors in cancer therapy<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/c-ciarn.ca\/?p=1240\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response - SGLT inhibitors in cancer therapy\" \/>\n<meta property=\"og:description\" content=\"\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response. in lots of demyelinating illnesses, including multiple sclerosis (MS). Although cytotoxic actions of myelin-specific T cells continues to be incriminated for the MS...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/c-ciarn.ca\/?p=1240\" \/>\n<meta property=\"og:site_name\" content=\"SGLT inhibitors in cancer therapy\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-07T09:52:43+00:00\" \/>\n<meta name=\"author\" content=\"webmaster\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"webmaster\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/c-ciarn.ca\\\/?p=1240#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/c-ciarn.ca\\\/?p=1240\"},\"author\":{\"name\":\"webmaster\",\"@id\":\"https:\\\/\\\/c-ciarn.ca\\\/#\\\/schema\\\/person\\\/8b6dc5d86359d0c93ab67fe896511b29\"},\"headline\":\"\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response\",\"datePublished\":\"2026-05-07T09:52:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/c-ciarn.ca\\\/?p=1240\"},\"wordCount\":701,\"articleSection\":[\"HATs\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/c-ciarn.ca\\\/?p=1240\",\"url\":\"https:\\\/\\\/c-ciarn.ca\\\/?p=1240\",\"name\":\"\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response - SGLT inhibitors in cancer therapy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/c-ciarn.ca\\\/#website\"},\"datePublished\":\"2026-05-07T09:52:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/c-ciarn.ca\\\/#\\\/schema\\\/person\\\/8b6dc5d86359d0c93ab67fe896511b29\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/c-ciarn.ca\\\/?p=1240#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/c-ciarn.ca\\\/?p=1240\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/c-ciarn.ca\\\/?p=1240#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/c-ciarn.ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/c-ciarn.ca\\\/#website\",\"url\":\"https:\\\/\\\/c-ciarn.ca\\\/\",\"name\":\"SGLT inhibitors in cancer therapy\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/c-ciarn.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/c-ciarn.ca\\\/#\\\/schema\\\/person\\\/8b6dc5d86359d0c93ab67fe896511b29\",\"name\":\"webmaster\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eb1cb4edef28458891be40d78fdfb788d3338b4756f4d8e49eb1f0a5dc22bd8b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eb1cb4edef28458891be40d78fdfb788d3338b4756f4d8e49eb1f0a5dc22bd8b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eb1cb4edef28458891be40d78fdfb788d3338b4756f4d8e49eb1f0a5dc22bd8b?s=96&d=mm&r=g\",\"caption\":\"webmaster\"},\"sameAs\":[\"http:\\\/\\\/c-ciarn.ca\"],\"url\":\"https:\\\/\\\/c-ciarn.ca\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response - SGLT inhibitors in cancer therapy","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/c-ciarn.ca\/?p=1240","og_locale":"en_US","og_type":"article","og_title":"\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response - SGLT inhibitors in cancer therapy","og_description":"\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response. in lots of demyelinating illnesses, including multiple sclerosis (MS). Although cytotoxic actions of myelin-specific T cells continues to be incriminated for the MS...","og_url":"https:\/\/c-ciarn.ca\/?p=1240","og_site_name":"SGLT inhibitors in cancer therapy","article_published_time":"2026-05-07T09:52:43+00:00","author":"webmaster","twitter_card":"summary_large_image","twitter_misc":{"Written by":"webmaster","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/c-ciarn.ca\/?p=1240#article","isPartOf":{"@id":"https:\/\/c-ciarn.ca\/?p=1240"},"author":{"name":"webmaster","@id":"https:\/\/c-ciarn.ca\/#\/schema\/person\/8b6dc5d86359d0c93ab67fe896511b29"},"headline":"\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response","datePublished":"2026-05-07T09:52:43+00:00","mainEntityOfPage":{"@id":"https:\/\/c-ciarn.ca\/?p=1240"},"wordCount":701,"articleSection":["HATs"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/c-ciarn.ca\/?p=1240","url":"https:\/\/c-ciarn.ca\/?p=1240","name":"\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response - SGLT inhibitors in cancer therapy","isPartOf":{"@id":"https:\/\/c-ciarn.ca\/#website"},"datePublished":"2026-05-07T09:52:43+00:00","author":{"@id":"https:\/\/c-ciarn.ca\/#\/schema\/person\/8b6dc5d86359d0c93ab67fe896511b29"},"breadcrumb":{"@id":"https:\/\/c-ciarn.ca\/?p=1240#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/c-ciarn.ca\/?p=1240"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/c-ciarn.ca\/?p=1240#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/c-ciarn.ca\/"},{"@type":"ListItem","position":2,"name":"\ufeffNitric oxide (Zero) and TNF release in culture media were measured as markers from the inflammatory response"}]},{"@type":"WebSite","@id":"https:\/\/c-ciarn.ca\/#website","url":"https:\/\/c-ciarn.ca\/","name":"SGLT inhibitors in cancer therapy","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/c-ciarn.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/c-ciarn.ca\/#\/schema\/person\/8b6dc5d86359d0c93ab67fe896511b29","name":"webmaster","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/eb1cb4edef28458891be40d78fdfb788d3338b4756f4d8e49eb1f0a5dc22bd8b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/eb1cb4edef28458891be40d78fdfb788d3338b4756f4d8e49eb1f0a5dc22bd8b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/eb1cb4edef28458891be40d78fdfb788d3338b4756f4d8e49eb1f0a5dc22bd8b?s=96&d=mm&r=g","caption":"webmaster"},"sameAs":["http:\/\/c-ciarn.ca"],"url":"https:\/\/c-ciarn.ca\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/c-ciarn.ca\/index.php?rest_route=\/wp\/v2\/posts\/1240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/c-ciarn.ca\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/c-ciarn.ca\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/c-ciarn.ca\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/c-ciarn.ca\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1240"}],"version-history":[{"count":1,"href":"https:\/\/c-ciarn.ca\/index.php?rest_route=\/wp\/v2\/posts\/1240\/revisions"}],"predecessor-version":[{"id":1241,"href":"https:\/\/c-ciarn.ca\/index.php?rest_route=\/wp\/v2\/posts\/1240\/revisions\/1241"}],"wp:attachment":[{"href":"https:\/\/c-ciarn.ca\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/c-ciarn.ca\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/c-ciarn.ca\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}